Matthew Davis

Matthew Davis

Corporate Officer/Principal chez AQUESTIVE THERAPEUTICS, INC.

Fortune : 511 000 $ au 31/08/2026

Health Technology
Consumer Services
Consumer Non-Durables

Profil

Dr. Matthew W.
Davis
, MD, is a Chief Development Officer at Aquestive Therapeutics, Inc. and an Adjunct Associate Professor at Temple University (Pennsylvania).
Dr. Davis was previously employed as a Chief Operating & Medical Officer by Tiziana Life Sciences Ltd. (United Kingdom), a Chief Operating & Medical Officer by Tiziana Life Sciences Ltd. (Bermuda), a SVP-Research & Development Branded Pharmaceuticals by Endo International Plc, a Vice President-Branded Products & Medical Affairs by URL Pharma, Inc., a Head-Medical Affairs by Dermik Laboratories, Inc., a Head-Clinical Development & Medical Affairs by Dr. Reddy's Laboratories, Inc., a Head-Medical Affairs & Pharmacovigilance by Endo Pharmaceuticals, Inc., a Chief Medical Officer by Lupin, Inc., and a Chief Medical Officer by Neuvivo, Inc. He received his undergraduate degree from Temple University School of Pharmacy and a doctorate degree from Drexel University College of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
09/03/2026 100 000 ( 0,08% ) 511 000 $ 31/08/2026

Postes actifs de Matthew Davis

SociétésPosteDébut
AQUESTIVE THERAPEUTICS, INC. Corporate Officer/Principal 04/11/2025
Corporate Officer/Principal -

Anciens postes connus de Matthew Davis

SociétésPosteFin
TIZIANA LIFE SCIENCES LTD Directeur des opérations 01/07/2024
Directeur Technique/Scientifique/R&D -
Directeur Technique/Scientifique/R&D -
Directeur des opérations -
ENDO INTERNATIONAL PLC Corporate Officer/Principal -
Voir l'expérience en détail de Matthew Davis

Formation de Matthew Davis

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

65

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées13

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Non-Durables

Health Technology

Health Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Matthew Davis